Zusammenfassung
Das klinische Bild und die Pathogenese des diabetischen Fußsyndroms (DFS) sind außerordentlich vielfältig. Grundlage der meisten Veränderungen sind die periphere diabetische Polyneuropathie und die daraus folgende Fehlbelastung der verschiedenen Strukturen des Fußes, Durchblutungsstörungen durch eine periphere arterielle Verschlusskrankheit sowie Infektionen. Die unterschiedliche Ausprägung dieser Hauptursachen führt zu der vielfältigen Klinik, die eine Zusammenarbeit verschiedener Berufsgruppen erforderlich macht, ohne die eine umfassende Behandlung der Vielfältigkeit des DFS nicht möglich ist. In dieser Übersicht soll insbesondere der Anteil der unterschiedlichen Berufsgruppen an der Prävention, Diagnostik und Behandlung des DFS herausgestellt werden. Nur durch die Koordinierung eines interdisziplinären Diabetes-Fuß-Teams ist eine adäquate Therapie des DFS erfolgreich.
Abstract
The clinical picture and pathogenesis of the diabetic foot syndrome are extraordinarily varied. The causes of the majority of lesions are peripheral diabetic polyneuropathy and the resulting incorrect distribution of pressure on structures of the foot, impairment of circulation due to peripheral arterial disease, as well as infections. The different aspects of these main causes result in a multifaceted clinical picture. Therefore, it is essential that different professional groups cooperate with one another; without this, comprehensive treatment of the many aspects of the diabetic foot syndrome is not possible. In particular, the present article attempts to highlight the part played by the different professional groups in the prevention, diagnosis and treatment of the diabetic foot syndrome. Only if an interdisciplinary diabetic foot team is coordinated and works together smoothly can successful therapy of the diabetic foot syndrome be achieved.
Literatur
Prompers L, Huijberts M, Apelqvist J et al (2007) High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the eurodiale study. Diabetologia 50:18–25
Van Houtum WH, Rauwerda JA, Ruwaard D et al (2004) Reduction in diabetes-related lower-extremity amputations in the Netherlands: 1991–2000. Diabetes Care 27:1042–1046
Jeffcoate WJ, van Houtum WH (2004) Amputation as a marker of the quality of foot care in diabetes. Diabetologia 47:2051–2058
Trautner C, Standl E, Haastert B et al (1997) Geschätzte Anzahl von Amputationen in Deutschland. Diabetes Stoffw 6:199–202
Heller G, Günster C, Schellschmidt H (2004) Wie häufig sind Diabetes-bedingte Amputationen unterer Extremitäten in Deutschland? Eine Analyse auf Basis von Routinedaten. Dtsch Med Wochenschr 129:429–433
Heller G, Gunster C, Swart E (2005) The frequency of lower limb amputations in Germany. Dtsch Med Wochenschr 130:1689–1690
Spraul M, Schönbach AM, Mühlhauser I, Berger M (1999) Amputationen und Mortalität bei älteren, insulinpflichtigen Patienten mit Typ 2-Diabetes. Zentralbl Chir 124:25–31
Trautner C, Haastert B, Spraul M et al (2001) Unchanged incidence of lower-limb amputations in a German city, 1990–1998. Diabetes Care 24:855–859
Trautner C et al (2007) Reduced incidence of lower-limb amputations in the diabetic population of a German city, 1990–2005. Results of the Leverkusen Amputation Reduction Study (LARS). Diabetes Care 30:2633–2637
Mueller MJ, Diamond JE, Sinacore DR (1989) Total contact casting in treatment of diabetic plantar ulcers. controlled clinical trial. Diabetes Care 12:384–388
Chantelau E, Breuer U, Leisch AC (1993) Outpatient treatment of unilateral diabetic foot ulcers with half shoes. Diabet Med 10:267–270
Piaggesi A et al (2007) An off-the-shelf instant contact casting device for the management of diabetic foot ulcers. A randomized prospective trial versus traditional fiberglass cast. Diabetes Care 30:586–590
Chantelau E (2005) The perils of procrastination: effects of early vs. delayed detection and treatment of incipient charcot fracture. Diabet Med 22:1707–1712
Holstein P, Ellitsgaard N, Olsen BB, Ellitsgaard V (2000) Decreasing incidence of major amputations in people with diabetes. Diabetologia 43:844–847
Wolfle KD, Schaal J, Rittler S et al (2003) Infrainguinal bypass grafting in patients with end-stage renal disease and critical limb ischaemia:Is it worthwhile? Zentralbl Chirurgie 128:709–714
Adam DJ, Beard JD, Cleveland T et al (2005) Bypass versus angioplasty in severe ischemia of the leg (Basil): a multicenter, randomised controlled trial. Lancet 366:1925–1934
Malmstedt J, Leander K, Wahlberg E et al (2008) Outcome after leg bypass surgery for critical limb ischemia is poor in patients with diabetes. A population –based cohort study. Diabetes Care 31:887–892
Lavery LA, Armstrong DG, Peters EJG, Lipsky BA (2007) Probe-to-bone test for diagnosing diabetic foot osteomyelitis. Reliable or relic? Diabetes Care 30:270–274
Game FL, Jeffcoate WJ (2008) Primarily non-surgical management of osteomyelitis of the foot in diabetes. Diabetologia 51:962–967
Berendt AR et al (2008) Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev 24 (Suppl1): S145–S161
Lipsky BA, Armstrong DG, Citron DM et al (2005) Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet 366:1695–1703
Morbach S, Müller E, Reike H et al (2008) Evidenzbasierte Leitlinie Diabetischer Fuß, 2. Aufl., Update unter http://www.deutsche-diabetes-gesellschaft.de/Leitlinien
Bergin SM, Wraight P (2006) Silver based wound dressings and topical agents for treating diabetic foot ulcers (Review). Cochrane Database Syst Rev CD005082
Jude EB, Apelqvist J, Spraul M, Martini J (2007) Prospective randomized controlled study of hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers. Diabet Med 24:280–288
Blume PA, Walters J, Payne W et al (2008) Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers. Diabetes Care 31:631–636
Chantelau E, Haage P (1994) An audit of cushioned diabetic footwear: Relation to patient compliance. Diabet Med 11:114–116
Uccioli L, Aldeghi A, Faglia E (1995) Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care 18:1376–1378
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehungen hin: Vortragshonorare: MSD Sharpe & Dohme, KCI, Novartis, Johnson & Johnson Woundmanagement, Bauerfeind, Medac, Mölnlycke, Abbott, Neubourg Skincare. Studienunterstützung: Wyeth, Pfizer, Mölnlycke, Sanuwave, Vivostat.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Spraul, M. Interdisziplinäre Behandlung des diabetischen Fußsyndroms. Diabetologe 5, 78–90 (2009). https://doi.org/10.1007/s11428-008-0349-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-008-0349-x